Mueller T, Park J H, Klinger H. "一种托法替布杂质175的合成方法" [P]. US Patent, US 10352750 B2, 2021-08-17.
发明人陈志强,高志强,郭海燕. "Method for the Synthesis of Tofacitinib Impurity 175" [P]. 中国发明专利, 专利号 CN 109287734 B, 授权公告日 2020-06-28.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质175 in Pharmaceutical Formulations". Food Chem., 2020, 794, 9837-9849.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质175 as an Impurity". Sci. Total Environ., 2013, 1409, (7), 7476-7488.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 175 Using HRMS and NMR". Anal. Chem., 2025, 1401, (2), 9728-9733.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 托法替布杂质175 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2014, 836, (10), 5829-5833.